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Abstract
The IFN-inducible antiviral protein tetherin (or BST-2/CD317/HM1.24) impairs release of mature HIV-1 particles from infected
cells. HIV-1 Vpu antagonizes the effect of tetherin. The fate of virions trapped at the cell surface remains poorly understood.
Here, we asked whether tetherin impairs HIV cell-to-cell transmission, a major means of viral spread. Tetherin-positive or -
negative cells, infected with wild-type or DVpu HIV, were used as donor cells and cocultivated with target lymphocytes. We
show that tetherin inhibits productive cell-to-cell transmission of DVpu to targets and impairs that of WT HIV. Tetherin
accumulates with Gag at the contact zone between infected and target cells, but does not prevent the formation of
virological synapses. In the presence of tetherin, viruses are then mostly transferred to targets as abnormally large patches.
These viral aggregates do not efficiently promote infection after transfer, because they accumulate at the surface of target
cells and are impaired in their fusion capacities. Tetherin, by imprinting virions in donor cells, is the first example of a surface
restriction factor limiting viral cell-to-cell spread.
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Introduction
HIV and many other viruses move not only as free viral
particles diffusing in the extracellular environment, but also
directly between cells [1]. Cell-to-cell spread accelerates viral
dissemination, and likely influences pathogenesis and immune
evasion [1]. Various modes of cell-to-cell HIV transfer have been
reported in culture. HIV-1 readily forms virological synapses (VS)
at the interface between HIV-infected cells and targets. VS
formation involves HIV Env-CD4-coreceptor interactions, and
requires cytoskeletal rearrangements and stabilization of cell
junctions by adhesion molecules [1,2]. Other modes of retroviral
cell-to-cell spread include polysynapses, which allow simultaneous
transfer to multiple targets [3], filopodial bridges or thiner
nanotube-like structures formed between infected cells and more
distant targets [4,5], and biofilm-like HTLV-I assemblies embed-
ded in extracellular matrix components [6]. HIV dissemination
through VS occurs within minutes and involves viral endocytosis
in target cells [7–9]. Type-I interferons (IFN) inhibit partially HIV
cell-to-cell transmission [10], but the interferon-induced protein(s)
responsible for this inhibition are not characterized.
Tetherin (also known as BST-2, CD317 or HM1.24) is an
interferon-induced protein recently identified as inhibiting the
release of retroviruses and other enveloped viruses [11–17]. The
non-structural Vpu protein of pandemic HIV-1 strains counteracts
tetherin, by inducing its removal from the cell surface and its
proteasomal and/or lysosomal-dependent degradation [11,12,18–
23]. Some primate lentiviruses that do not encode Vpu may use
Nef or Env to antagonize tetherin [24–28]. A few viruses (SIVcpz
and SIVgor) also use Nef to down-regulate tetherin, although they
contain Vpu genes [28]. Moreover, there are species-specific
activities of Vpu and Nef in overcoming restriction by tetherin
[24–29]. The mechanism of action of tetherin is partly understood.
Tetherin dramatically inhibits the release of DVpu virions and
moderately affects that of WT HIV [11,12,30]. In infected cells,
tetherin colocalizes with Gag proteins [11,12], and retains fully
formed and mature viral particles at the cell surface [30,31].
Tetherin is an integral membrane protein, with a short N-terminus
located in the cytoplasm, which carries sorting signals for the
endocytic machinery, and a glycosyl-phosphatidylinositol (GPI)
anchor at the C-terminus [11,32–34]. The protein is enriched in
lipid rafts, which are sites of viral assembly and release [35,36].
Tetherin is directly incorporated in budding virions as a parallel
homodimer and restrains them at the cell surface [30,31].
Tetherin binds to BCA2/Rabring7 to promote restriction [37].
Proteolysis of tetherin ectodomain releases virions retained on the
cell surface, but cleavage of the GPI anchor does not [31].
Remarkably, an artificial tetherin-like protein, lacking sequence
homology but mimicking its structure, recapitulated the antiviral
activity [30]. The fate of membrane-tethered virions is not well
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Rabring7-, Rab5a- and clathrin-dependent mechanism [38] [37]
but a large part remains at the cell surface, forming aggregates
[11,12,38].
Here, we asked whether the membrane-bound virions trapped
by tetherin may be transmitted during intercellular contacts, and
examined the impact of this restriction factor on viral cell-to-cell
transmission and VS formation.
Results
We analyzed the influence of Vpu on HIV cell-to-cell
transmission. We cocultured for 2 h WT- or DVpu-infected cells
with primary CD4+ lymphocytes, and then harvested the target
lymphocytes. We then followed productive viral spread to
lymphocytes by measuring by flow-cytometry the appearance of
Gag+ cells, as outlined Figure 1a. We first used as donors HeLa
cells, that constitutively express tetherin, or Hela-THN- cells, in
which the protein was silenced (Figure S1a). Productive entry of
viruses in HeLa or HeLa-THN- cells (which lack the CD4
receptor) was ensured by pseudotyping WT or DVpu virions with
the VSV-G envelope. HeLa cells, with similar levels of infection
(15–20% of Gag-expressing cells, as assessed by flow cytometry),
were then cocultivated with CD4+ lymphocytes. WT HIV was
efficiently transmitted to targets, with about 20% of lymphocytes
expressing Gag after 18 h (Figure 1b). Nevirapine, a reverse-
transcriptase inhibitor, significantly decreased the appearance of
Gag in targets, confirming that the signal mostly originates from
newly synthesized viral proteins, and not from capture of incoming
virions (not shown). Transmission of WT HIV was slightly affected
by tetherin. This confirmed that tetherin inhibition by Vpu is not
absolute [12,31] and likely depends on the relative levels of the two
proteins. DVpu was transmitted from HeLa-THN- cells, but much
less potently from HeLa cells (Figure 1b). A compilation of
independent experiments, with lymphocytes from different donors,
indicated that tetherin significantly decreased Gag expression in
DVpu recipient cells (two-fold reduction) (Figure 1c). Similar
results were obtained when Jurkat lymphoid cells were used as
targets (Figure 1c). Thus, tetherin decreases HIV cell-to-cell
transmission. Vpu counteracts this phenomenon. Noteworthy, the
inhibitory effect of tetherin on DVpu was counteracted by
transient transfection of a Vpu expression plasmid in donor HeLa
cells, excluding the possibility that the expression of Vpu in targets
may have biased the results (not shown).
We then used 293T cells as donors, since they do not naturally
express tetherin. We examined if transient expression of tetherin
inhibited viral cell-to-cell spread. To this end, 293T cells were
cotransfected with WT or DVpu HIV proviruses, along with a
control or a tetherin expression plasmid. An amount of 100 ng of
tetherin plasmid was selected, since it potently inhibited release of
DVpu, without affecting that of WT HIV (Figure S1b). Upon
coculture of transfected cells with Jurkat cells, DVpu transmission
to target lymphocytes was decreased by tetherin, whereas WT
HIV was minimally impaired (Figure 2a). A compilation of 6
independent experiments confirmed a significant reduction (two-
fold) of DVpu transmission from tetherin positive cells, when
compared to negative cells (Figure 2b). We next evaluated the
contribution of cell-free viral particles to the productive infection
of target cells. We previously reported that a gentle agitation of
cocultures inhibits HIV spread through direct cell contacts without
impairing infection by free virions [39]. Shaking cocultures of
293T donor cells and Jurkat target cells strongly inhibited the
appearance of Gag+ cells in targets, irrespectively of the presence
of tetherin or Vpu in donors (Figure 2b). Therefore, under these
experimental conditions, most of productive viral transmission
occurs through intercellular contacts. The contribution of cell-free
virions is minimal.
To describe further the impact of tetherin on HIV cell-to-cell
spread, we transfected different amounts of tetherin expression
plasmids (Figure S1b). At low amounts (20 ng of transfected
DNA), DVpu release in supernatants was inhibited, without
obvious effects on cell-to-cell transmission. With high levels of
tetherin (200 ng), DVpu release and transmission were both
restricted. This was also the case for WT HIV. Therefore, as
previously reported for viral release [11,12,30], the effect of
tetherin on cell-to-cell spread is dose-dependent. The anti-tetherin
activity of Vpu is not absolute, and tetherin inhibits more easily
viral release than cell-to-cell transmission.
We then asked whether tetherin, when induced by type-I
interferon (IFN), restricts intercellular viral spread. We generated
293T cells that carry an shRNA against tetherin (293T-shTHN) or
a control shRNA (293T-shCtr). Flow-cytometry indicated that
IFN induced tetherin in 293T control cells, but not in 293T-
shTHN cells (Figure 2c). Upon IFN treatment, cell-to-cell spread
of DVpu was significantly impaired in control cells (two-fold
decrease), and occurred normally in tetherin-silenced 293T cells
(Figure 2c). Therefore tetherin is the major interferon-induced
protein impairing HIV cell-to-cell transfer in this experimental
setting.
It was important to determine whether tetherin also inhibits
lymphocyte-to-lymphocyte viral transfer. Primary lymphocytes,
naturally expressing tetherin (not shown), were infected with WT
or DVpu HIV, and were then cocultivated with uninfected target
lymphocytes, where the appearance of Gag+ cells was measured
over time. With WT HIV, about 30% of Gag+ targets were
detected at 48 h. This signal was only partly inhibited in the
presence of Nevirapine, suggesting that it corresponds to a mix of
newly synthesized Gag proteins and incoming viral materials
bound to targets (Figure 2d). DVpu was significantly less
transmitted to recipient lymphocytes. T. Interestingly, in the
presence of Nevirapine, the % of Gag+ target cells was not
significantly different for WT and DVpu (Figure 2d), suggesting
that uptake of incoming viral materials by targets is not inhibited
Author Summary
Tetherin is a cell surface ‘‘restriction factor’’ that acts as an
innate antiviral defense. Tetherin prevents newly produced
particles of HIV-1 and other enveloped viruses from
escaping the surface of infected cells. HIV-1 encodes the
protein Vpu to counteract this host defense. We have
studied here if HIV-1 particles trapped at the cell surface
may be transmitted to neighboring uninfected cells. Direct
transmission through cell-to-cell contacts is indeed an
efficient means for viral spread. Virological synapses may
be formed between infected donor cells and target cells,
allowing rapid and massive transmission of viruses. We
show that tetherin inhibits productive cell-to-cell trans-
mission of Vpu-deleted HIV to target cells, and impairs that
of wild-type virus. Tetherin accumulates with Gag at the
contact zone between infected and target cells, but does
not prevent the formation of virological synapses. With
tetherin, viruses are then mostly transferred to targets as
abnormally large patches that are impaired in their fusion
capacities. These results represent the first example of a
surface restriction factor limiting viral cell-to-cell spread,
acting in donor cells, but inhibiting infection after transfer
of viral material to novel recipient cells.
Tetherin and HIV-1 Cell-to-Cell Transmission
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infection of target cells is studied further below. A decrease of
DVpu productive transmission was observed when various T cell
lines (MT4C5, Jurkat, or CEM) all expressing tetherin, were used
as donors or targets (not shown and Figure 2e for an example of
viral transfer from MT4C5 to Jurkat cells). To directly assess the
role of tetherin in lymphocytes, we generated CEM cells in which
expression of the protein was silenced (CEM-THN-, with about
90% of Tetherin down-regulation, Figure S2a). CEM-THN-
transmitted more efficiently DVpu to target lymphocytes than
parental CEM cells (Figure S2b). Altogether, these results show
that tetherin significantly reduces HIV cell-to-cell transmission
from various primary and permanent cell types (HeLa, 293T, and
lymphocytes).
Figure 1. Tetherin reduces HIV cell-to-cell transmission. (a) Schematic representation of the cell-to-cell transfer assay. (b) HIV cell-to-cell
transmission analyzed by flow cytometry. Hela donor cells expressing (black squares) or not expressing (white squares) tetherin (THN) were infected
with WT (left panel) or DVpu (right panel) HIV. Cells were then cocultivated with target lymphocytes. The percentage of Gag+ cells in targets, at
different time points is shown in this representative experiment. (c) Mean6sd (black line) of 4 and 7 independent experiment (20 h time point) with
primary T cells (left) and Jurkat T cells (right) as targets, respectively. *p,0.05; **p,0.01 (Mann-Whitney test).
doi:10.1371/journal.ppat.1000955.g001
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whether the protein affected VS formation in lymphocytes. We
measured the recruitment of Gag proteins at the contact zone
between donors and recipients, a hallmark of VS formation [1].
Lymphocytes (MT4C5 T cell line) were infected with Vpu positive
or negative viruses. With DVpu, the cell surface Gag signal was
generally more intense than with WT, and appeared mostly as
large patches of fluorescence, reflecting the trapping of virions
(Figure S3a). In non-infected MT4C5 cells, tetherin was found at
the cell periphery and in intracellular compartments (Figure S3a),
Figure 2. Tetherin reduces HIV cell-to-cell transmission from 293T and primary T cells. (a) Effect of transient expression of tetherin. 293T
cells donor cells were cotransfected with WT (left panel) or DVpu (right panel) HIV proviruses, along with a control (white squares) or a tetherin
expression plasmid. Cells were then cocultivated with target Jurkat cells for 2 h. The percentage of Gag+ cells in targets, at different time points after
harvesting the targets, is shown in this representative experiment. (b) Mean6sd (black line) of 6 independent experiment (20 h time point) with
Jurkat T cells as targets. When stated (in 3 out of 6 experiments), cocultures were gently shaken to inhibit intercellular contacts *p,0.05; **p,0.01
(Mann-Whitney test). (c) Tetherin expression in IFN-treated 293T cells stably expressing a control shRNA (continuous line) or an shRNA targeting THN
(dotted line). Grey histogram: cells not treated with IFN. Cell-to-cell transfer using infected 293T cells as donors and Jurkat as targets (right panels).
Mean6sd of 3 independent experiments is depicted. (d) HIV transfer between primary T cells. Donor lymphocytes were infected with WT (white
squares) or DVpu (black squares) HIV. The percentage of Gag+ cells among targets is shown at the indicated times points in this representative
experiment. Right: mean (black line) 6sd of 4 independent experiments. Targets were treated or not with Nevirapine (NVP), a reverse transciptase
inhibitor, after coculture. (e) Compilation of 3 independent experiments using MT4C5 T cells as donors and Jurkat as targets. Data are mean 6sd. b,
c, e: 20 h time point; d: 48 h time point. *p,0.05; **p,0.01 (Mann-Whitney test).
doi:10.1371/journal.ppat.1000955.g002
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[11,12,32]. As expected, tetherin colocalized with Gag at the
surface of DVpu-infected cells, and was down-regulated in WT-
infected cells (Figure S3a). Infected cells were then incubated for
1 h with recipient lymphocytes (Jurkat cells stained with Far Red
dye). The percentage of Gag+ donor cells forming conjugates with
Far Red+ cells was similar with WT and DVpu viruses (not
shown). About 30% of conjugates displayed a polarization of Gag
at the junction, irrespectively of the presence of Vpu (Figure 3b).
Interestingly, with DVpu, the large Gag-containing patches
accumulated at the contact zone (Figure 3a). We then investigated
the distribution of tetherin in conjugates of infected cells and
targets. The protein colocalized with Gag at the synapse in about
80% of conjugates with DVpu, whereas it was much less present in
WT-induced synapses, probably as a direct consequence of Vpu-
mediated removal of tetherin from the cell surface (Figures 3a,c).
Tetherin also accumulated at the intercellular zone when tetherin-
negative Jurkat cells were used as targets (Figure S3b), strongly
suggesting that molecules found at the VS originated from donors,
without requiring the presence of the antiviral protein in targets.
Tetherin enrichment was not detected with control non-infected
donors mixed with targets (not shown). Altogether, these results
show that tetherin does not prevent Gag polarization and VS
formation, and accumulates with Gag proteins at the junction
zone.
We next visualized the spatio-temporal events leading to viral
transfer in living cells. We used an infectious HIV-GagGFP virus
[3] and its Vpu-deleted counterpart. Jurkat cells producing WT
and DVpu HIV-GagGFP were cocultivated with targets that
expressed a red fluorescent protein (RFP)-actin, and images were
acquired every 20 s for 2 h. As previously reported [3,8],
virological synapses or polysynapses readily formed with WT
HIV, illustrated by Gag polarization at the junction and
subsequent transfer (Video S1 and Figure 3d). In donor cells,
DVpu HIV-GagGFP often appeared as patches which were larger
than those observed with its Vpu-positive counterpart (Video S2
and Figure 3d), likely reflecting the activity of tetherin [11,12].
Time-lapse analysis showed that the large patches of Gag proteins
originated from all regions of the plasma membrane and gained
access to intercellular contact zones (Video S2 and Figure 3d).
Both WT and DVpu viral materials from donor cells were then in
part transferred to recipient cells (Videos S1 and S2).
What is the behavior of WT and DVpu viruses after their
transfer to target cells? Infected HeLa cells were cocultivated with
Jurkat cells, targets were harvested after 2 h, and Gag distribution
was examined. We readily distinguished two types of Gag staining
after transfer, the first corresponding to small and discrete puncta,
and the second associated with large aggregates of Gag proteins
(Figure 4a). These two viral species mirrored those observed in
donor cells. WT HIV was mostly transferred as small clusters,
whereas DVpu appeared as large aggregates in 70% of the targets
(Figure 4a). The number of DVpu-infected cells displaying large
clusters was strongly reduced when HeLa-THN- were used as
donors (Figure 4a). To document further these large Gag-positive
bundles in target cells, we followed the localisation of DVpu HIV-
GagGFP on targets by correlative microscopy analysis. This
technique combines fluorescence and scanning electron micros-
copy of the same samples over a wide range of magnification. The
Gag signal corresponded to an agglomeration of viral-like particles
(VLPs), each with a size of about 100 nm, assembled as large
clusters (Figure 4b). Immunogold staining revealed that these
VLPs were decorated with HIV Env+ dots, and likely corre-
sponded to HIV-1 virions (Figures 4b and S4). These VLPs were
not visible in non-infected cells (not shown and [3]). Additional
immunofluorescence stainings on target cells confirmed a
colocalization of Gag and Env (Figure S5a). Moreover, target cell
membrane labelling with cholera toxin, a raft marker, suggested
that these Gag clusters accumulated at the surface (Figure S5b).
These large patches were still observed 15 or 24 h after harvesting
the targets, and are thus relatively long-lived (Figure 4c). The
conglomeration of Gag in recipient Jurkats similarly occurred after
coculture with DVpu-infected lymphocytes (Figure 5a), and is thus
not due to the use of HeLa as donors. Furthermore, these large
aggregates were positive for tetherin (Figures 5a and S5c). The
tetherin signal originated from donors, since it was detected when
using tetherin-negative Jurkat recipients (Figure 5a). Therefore,
tetherin is transferred along with HIV particles to recipient cells.
These observations are consistent with the incorporation of
tetherin into virions [30,31].
Productive cell-to-cell transfer of the R5 tropic AD8DVpu strain
to MT4-CCR5+ cells was also inhibited by tetherin (Figure S6a).
With AD8DVpu, the large characteristic patches of Gag-positive
material were also readily detected in target CCR5-negative Jurkat
cells and CCR5+ primary CD4+ lymphocytes (Figure S6b), and
not in a CD4-negative Jurkat subclone (not shown). The results
suggest that transfer of these viral patches requires CD4 binding
but not coreceptor expression in recipient cells. This event,
however, did not lead to productive infection in the absence of
CCR5 (not shown). These results also demonstrate that tetherin
can restrict intercellular spread of X4 and R5 viruses.
We further documented by real-time imaging the fate of viruses
after their transfer to targets. After 2 h of coculture with WT and
DVpu HIV-GagGFP producer cells, Jurkat cells were harvested
and monitored for up to 6–8 h (Figure 5b and Videos S3 and S4).
At time zero post coculture, DVpu viral aggregates were
apparently larger, and more numerous than WT virions. A
standardized quantification demonstrated a 7-fold increase in the
fluorescent signal per cell with DVpu (Figure 5c). This confirmed
that the impaired productive infection of targets did not result
from a reduced transfer of viral material. The fate of incoming
viral particles was apparently different with WT and DVpu. In the
presence of Vpu, the punctate fluorescent signals decreased in
number and intensity overtime. In addition to signal quenching,
this decrease may reflect viral detachment, endocytosis, degrada-
tion or fusion events (Figure 5b and Video S3). In the absence of
Vpu, the large patches were apparently stable, some of them
remaining visible at the plasma membrane after 6–8 h (Figure 5b
and Video S4).
We then assessed the early events of viral replication in targets
by quantifying viral DNA synthesis. HeLa and HeLa-THN- cells,
infected with WT and DVpu HIV, were cocultivated with Jurkat
cells for 1 h. Target cells were then harvested, further incubated at
37uC and analyzed as a function of time by qPCR for the presence
of reverse transcription (RT) products. Nevirapine was included as
a control to ensure that the detected PCR products were the result
of proviral DNA neosynthesis (Figures 5 d, e). With WT, we
observed an increase of RT products overtime, reaching about 10
copies per cell at 24 h after infection (Figures 5 d,e). Viral DNA
synthesis was similar when tetherin positive and negative cells were
used as donors (Figures 5 d,e). The situation was different with
DVpu. With tetherin-negative donors, viral DNA synthesis
occurred efficiently, reaching 10–15 copies at 24 h, which is even
slightly higher than levels observed with the WT virus (Figures 5
d,e). Tetherin drastically reduced the appearance of RT products,
which barely exceeded background levels observed in Nevirapine-
treated cells. Therefore, tetherin, when expressed in donor cells,
imprints the virus, resulting in a strong decrease (5 fold reduction)
of viral DNA synthesis after viral transfer to targets.
Tetherin and HIV-1 Cell-to-Cell Transmission
PLoS Pathogens | www.plospathogens.org 5 June 2010 | Volume 6 | Issue 6 | e1000955Figure 3. Tetherin accumulates with Gag at the virological synapse. (a) Localization of Gag and tetherin at the virological synapse. WT or
DVpu HIV-infected MT4C5 cells were mixed with far-red-dye labeled Jurkat recipients (blue) for 1 h, and stained for HIV-1 Gag (green) and tetherin
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viral cycle. We hypothesized that the fusion ability of the viral
aggregates could be reduced. We adapted a cell-free virion-based
assay [40] to analyze viral fusion after cell-to-cell transfer. This
assay involves the use of viruses containing a beta-lactamase-Vpr
(BlaM-Vpr) protein chimera (see experimental outline Figure 6a).
After 2 h of coculture with infected cells, target cells are harvested.
The successful cytoplasmic access of Blam-Vpr as a result of fusion
is monitored by the enzymatic cleavage of CCF2-AM, a
fluorogenic substrate of beta-lactamase loaded in targets. We used
as donor HeLa cells endogenously expressing tetherin, and
producing WT and DVpu HIV. Fusion of the wild-type virus
was readily detected, with more or less 5% of target Jurkat
harbouring cleaved CCF2-AM (Figures 6b,c). There was a
significant (2.7 fold) decrease of fluorescent targets with DVpu
(Figures 6b,c). We used as control donors cells producing an Env-
deleted (DEnv) or a fusion-defective HIV (F522Y mutant, that
carries a point mutation in Env abrogating fusion but retaining
CD4 binding [41,42]). None of these two mutants scored positive
(Figures 6b,c), confirming that the assay detects viral fusion, and
not virion endocytosis [40]. Furthermore, a gentle shaking of the
cocultures inhibited the appearance of cleaved CCF2-AM+ target
cells (Figure S7) strongly suggesting that cell-free viral particles
play a minor role in this viral fusion assay. Altogether, our results
demonstrate that tetherin impairs viral fusion and subsequent
productive infection of target cells.
Discussion
We show here that tetherin inhibits HIV cell-to-cell spread
through an unexpected mechanism. With tetherin, virions are
known to be trapped at the cell surface [11,12], and to form
aggregates. When infected cells harbouring these structures
encounter uninfected cells, viral aggregates are routed to
intercellular junction zones, and VS are formed quite normally.
Tetherin also accumulates at the VS. This leads to the transfer of
large aggregates of viral material to target lymphocytes. Scanning
electron microscopy and immunofluorescence analysis demon-
strated that aggregates reaching target cells are composed of viral
particles stuck together, and likely incorporating tetherin in their
membrane [30,31]. The subsequent steps of viral replication are
impaired. The viral conglomerates are able to move or surf at the
surface of target for hours, as visualized by real-time imaging, but
they lead to low levels of viral DNA synthesis. These results
demonstrate dissociation between the physical ‘‘transfer’’ of viral
materials to targets, which is not affected by tetherin and the
subsequent infection, or ‘‘productive transmission’’ [43], which is
blocked by the restriction factor.
We further show that the fusion process itself, leading to access
of incoming viral material to the cytosol of target cells, is inhibited.
Viral fusion is known to occur at the cell surface, or more
efficiently after viral endocytosis [8,44]. Our results strongly
suggest that these clusters of viral particles do not fuse at the cell
surface and/or are not adequately internalized. It is also
noteworthy that both incoming virions and newly synthesized
viral proteins generate the Gag signal in targets, when measured
by flow cytometry. The proportion of these two signals varies
when tetherin is present or absent in donor cells. This likely
explains the modest but significant decrease (two-fold reduction) in
the appearance of Gag+ cells induced by tetherin. Measuring viral
infectivity after transfer by following viral DNA synthesis
underscored a more marked inhibitory activity of tetherin (five-
fold decrease).
How does tetherin act? We report here that the antiviral protein
is necessary in donor cells, and not in targets (not shown), to block
productive cell-to-cell transfer. Moreover, in recipient cells, the
presence of CD4 (and not that of HIV coreceptors) is necessary to
promote transfer of viral aggregates. The strength of virus
trapping, which likely relies on non-covalent interactions [31], is
thus not sufficient to prevent viral transfer through Env/CD4
interactions. Tetherin has been recently demonstrated to act
directly on viral release by infiltration of viral membranes [30,31].
This infiltration likely explains our observation that tetherin is co-
transferred with particles. One can hypothesize that tetherin not
only physically tethers virions together, but also interferes, either
directly or indirectly, with a post-binding event. The packed
accumulation of virions may prevent fusion or endocytosis, for
instance by sterically blocking the function of Env. Tetherin itself,
when associated with viral membranes, may additionally impair
the ability of Env glycoproteins to mediate fusion. Alternatively,
tetherin, as a GPI-anchored raft protein, might trigger the transfer
of raft-associated cellular components that affect viral infectivity.
These non-mutually exclusive possibilities will require further
investigations. Noteworthy, we observed here that in the absence
of tetherin, DVpu is slightly but reproducibly more transmitted
than WT HIV. This may in part explain why Gummuluru et al
selected an HIV mutant lacking a functional Vpu protein in an
assay aimed at identifying fast-growing strains [45]. Vpu exerts
diverse activities, and for instance down-regulates CD4 expression
on infected cells. The global impact of Vpu on viral fitness is likely
the consequence of tetherin-dependent and independent effects.
Our results show that tetherin significantly impairs HIV cell-to-
cell transmission, which is a major means of viral replication in
culture systems [39]. The inhibition of productive cell-to-cell
transfer is directly linked to the trapping of virions at the surface of
donors. Tetherin provides a physical link between lipid rafts and
the apical actin network in polarized epithelial cells [33]. It will be
of interest to determine further the role of rafts and of the actin
cytoskeleton, which both regulate HIV cell-to-cell transfer [1], in
the effects of tetherin.
Tetherin is able to inhibit the release of a variety of enveloped
viruses, including other retroviruses (alpha-, beta- and delta-
retrovirus, lentivirus, spumaretrovirus) and filoviruses (Marburg
and Ebola viruses) [13,14]. Most of viral species also spread
through direct cell-to-cell spread [1]. HTLV-I is of special interest,
since this virus is barely released from the cell, and replicates
primarily by direct cell-to-cell transfer. Tetherin silencing
enhances HTLV-I release [13]. In HTLV-I infected cells, large
viral assemblies are present at the plasma membrane. These
aggregates, termed viral biofilms, include components of the
extracellular matrix, are positive for tetherin, and keep infectious
potential after detachment [6]. Our results suggest that HIV
(red). Representative images are shown. (b) Quantification of infected MT4C5 cells displaying Gag clustering at the junction zone with targets. Data
are mean6sd of 5 independent experiments (with a least of 650 Gag+ cells analyzed for each condition). (c) Quantification of virological synapses
displaying tetherin clustering at the junction zone. Data are mean6sd of 5 independent experiments (with a least of 200 synapses analyzed for each
condition). (d) Live video-microscope imaging of cell-to-cell transfer. Jurkat cells transfected with WT or DVpu HIV-GagGFP were mixed with actin-RFP
expressing Jurkat targets and analyzed. A 3D image was acquired every 20 seconds for 2 hours. 2D maximum-projection of the images is shown
Elapsed time after mixing is indicated. Corresponding sequences are supplementary Videos S1 (HIV-GagGFP WT) and S2 (HIV-GagGFP DVpu). *p,0.05
(Mann-Whitney test).
doi:10.1371/journal.ppat.1000955.g003
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red dye (blue) were harvested after 2 h of contact with WT or DVpu HIV-Gag-GFP transfected HeLa. Representative images are shown. In the right
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infectivity and fate, since HIV aggregates are poorly infectious,
much less than ‘‘individual’’ virions. Whether DVpu virions may
be embedded in biofilm-like structures, together with components
of the extracellular matrix, will require further investigation. It
would be also of interest to determine whether these HIV
aggregates, detached from donor cells for instance by a mechanical
or chemical treatment, are effected in their fusion and infectivity
capacities.
The physiological role of tetherin is not fully understood. This
protein is induced by IFN or other stimuli in some cells including
T lymphocytes, whereas it is constitutively expressed on other cell
types like epithelial cells or plasmacytoid DCs. It is thus tempting
to speculate that tetherin will act as a broad inhibitor of
intercellular spread of various viruses in diverse cell types.
Moreover, several viruses have evolved tetherin antagonists. It
will be worth examining the role of these viral proteins during viral
transmission.
In summary, we have demonstrated here that tetherin is an
innate restriction factor limiting HIV cell-to-cell spread. This IFN-
inducible protein acts through an original mechanism, by
imprinting viruses in donor cells, and significantly reducing their
infectious potential once they have been transferred to target cells.
Materials and Methods
Cells
Jurkat (clone 20), CEM and MT4C5 T lymphoid cells, Hela,
and 293T cells were grown as described [3]. Primary CD4+ T cells
were purified from human peripheral blood by density gradient
centrifugation (Lymphocytes separation medium, PAA) followed
by negative immunomagnetic selection (Miltenyi). About 98% of
cells were CD4+CD3+. For activation, primary T cells were
treated with phytohemagglutinin (PHA) (1 mg/ml) for 24 h at
37uC and then cultured in interleukin 2 (IL-2)-containing medium
(50 IU/ml). Hela, 293T and CEM cells were electroporated
(BioRad Gene pulser) with pRS-TI357703, coding for a 29-mer
shRNAs targeting BST2 mRNA, or pRS expressing an off-target
control (OriGene) [12]. Following electroporation, stable cell lines
were generated by puromicyn selection (1 mg/ml). Resistant cell
lines were then maintained in puromycin. Our Jurkat cells
are naturally heterogenous in surface expression of tetherin.
We directly sorted tetherin-negative cells from the parental
population.
Virus, infections and transfections
Virus stocks were prepared by transfection of 293T cells as
described [3]. Cells were infected with the X4 HIV-1 strains NL4-
3 or the NL4-3DVpu (referred to as HIV or HIVDVpu), or when
stated with the R5 strains AD8 WT and DVpu (a kind gift of Klaus
Strebel) [46]. For infection of Hela and 293T cells, viruses
pseudotyped with the vesicular stomatitis virus G protein were
used to allow viral entry in absence of receptor expression.
Infection was monitored by flow cytometry [39]. For HIV-
GagGFP experiments, a Vpu-deleted version of pNLC4-3
EGFP
[47] was a kind gift of Fabrizio Mammano. The EcoRI-BamHI
fragment (containing env and vpu) of pNL4-3DVpu [46] was
inserted in place of the EcoRI-BamHI fragment in pNLC4-3
EGFP.
HeLa cells were co-transfected with pNL4-3 and pNLC4-3
EGFP
proviral vectors, or their Vpu deleted counterparts, by lipofection
(Metafectene, Biontex) following manufacturer’s instructions. 1 mg
of each proviral vector was used to transfect 10
6 cells.
Analysis of cell-to-cell HIV transfer by flow cytometry
Infected or transfected Hela or 293T donor cells were plated in
24 well plates at a final concentration of 0.15610
6/ml. Two days
later, when about 15–20% of the donor cells were Gag+, target
cells were added to donor cells at a final concentration of 2610
6/
ml in a final volume of 250 ml/well. Target cells were prelabelled
with CellTrace Far Red DDAO-SE dye (1 mg/ml; Molecular
Probes) for 10 min at 37uC. When stated, cocultures where gently
shaken to inhibit intercellular contacts, as described [39]. After
2 hours of coculture, target cells were harvested, washed, and
incubated at 37uC. At the indicated time points, cells were stained
for intracellular Gag expression as described above and analyzed
by flow cytometry. When stated, the reverse-transcriptase
nevirapine (NVP 25 nM) was added 0.5 h before coculturing
and maintained during the assay. With primary CD4+ T cells or T
cell lines donors, the cell-to-cell transfer assay was conducted as
previously described [39].
Quantitative PCR of HIV DNA in target cells
Total DNA was extracted from target Jurkat cells using
QIAamp DNA mini kit (QIAGEN, Courtaboeuf, France). Total
HIV-1 DNA, including integrated and unintegrated HIV-DNA,
was quantified in Jurkat cells by real-time PCR (amplification of a
LTR region) [48].
Correlative light-scanning electron microscopy (SEM)
Jurkat cells harvested after coculture with HeLa cells
expressing HIV-Gag-GFP viruses were loaded on cell-locator
glass-bottom dishes (MatTek Corporation) coated with poly-
lysine. Cells were fixed in 4% PFA/0.1% Glutaraldehyde and
prepared for correlative light-scanning electron microscopy (CL-
SEM). Specific areas were imaged and localized with high
resolution on the cell-locator glass-bottom dishes by using a Zeiss
LSM510 microscope. Z series of optical sections were performed
at 0.2 mm intervals. For subsequent SEM analysis, the same cells
were refixed with 4% PFA for 1 hour. Immuno-gold labeling of
HIV envelope (gold particles: 20 nm) was performed with anti-
Gp120 mAb (110.H, Hybridolabs, Pasteur). Cells were fixed in
2.5% GA in 0.2 M cacodylate buffer (pH 7.2) overnight at 4uC,
then washed for 5 minutes three times in 0.2 M cacodylate buffer
(pH 7.2), post-fixed for 1 hour in 1% osmium, and rinsed with
distilled water. Cells were dehydrated through a graded series of
ethanol followed by critical point drying with CO2.D r i e d
specimens were sputter-coated twice with carbon with a gun ionic
evaporator PEC 682. The coordinates of the correlative cells
imaged with fluorescent microscopy were recovered in a JEOL
JSM 6700F field emission scanning electron microscope operat-
ing at 7 kV.
panel, quantification of target cells displaying large aggregates of Gag-GFP proteins after 2 h of coculture with WT or DVpu HIV-transfected HeLa
(white) or HeLa-THN- cells (black). Data are mean6sd of 9 independent experiments (with a least of 2000 Gag+ cells analyzed for each condition).
Similar results were obtained with parental WT or DVpu viruses lacking GFP, and staining with Gag mAbs (not shown) (b) Correlative electron
microscopy analysis of Jurkat targets after coculture with DVpu HIV-GagGFP transfected Hela cells. Viral aggregates appearing as green spots in the IF
image were visualized by SEM. Cells are stained with anti-Env MAb coupled to 20 nm-gold particles (appearing as white dots). (c) Long-lived Gag
patches on target cells. Jurkat cells were harvested after 2 h of contact with DVpu HIV-Gag-GFP transfected HeLa and incubated at 37uC in presence
of nevirapine. Representative images of gag signal at different time points after coculture are shown.*p,0.05; ***p,0.005 (Mann-Whitney test).
doi:10.1371/journal.ppat.1000955.g004
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For conjugates analysis, HIV-infected donor T-cells were mixed
with target cells (pre-labelled with CellTrace Far Red DDAO-SE,) at
a 1/1 ratio and loaded on polylysine-coated coverslips (0.6610
6cells
in 400 ml). After 1 h at 37uC, cells were fixed. For the analysis of
target cells, HIV-infected donor HeLa cells were mixed with
0.5610
6cells target cells (pre-labelled with CellTrace Far Red
DDAO-SE). After 2 hours of coculture, target cells were harvested,
washed, and incubated at 37uC. At the indicated time points, target
cells were loaded on polylysine-coated coverslips (0.5610
6cells in
400 ml), and fixed. Cells were stained with the following antibodies:
rabbit anti-Gagp24 (NIH AIDS reagents program- #384), rabbit
anti-Gagp24 (anti-MA, a kind gift of Pierre Boulanger), anti-tetherin
(BST-2 purified MaxPab mouse polyclonal antibody B02P, Abnova
or, a mouse anti-human BST2 monoclonal antibody (HM 1.24 -
kindly provided by Chugai Pharmaceutical, Co.), anti-Gp120 mAb
(110.H, Hybridolabs, Pasteur), FITC-conjugated cholera toxin
(ChTx) subunit B (5 mg/ml, Sigma on ice). Confocal microscopy
analysis was carried out with a Zeiss LSM510 microscope as
described [49]. Z series of optical sections were performed at 0.2 to
0.5 mm intervals. Levels of tetherin at the cell surface were
determined by flow cytometry with the HM1.24 mAb.
Virus-target cells fusion assay
The cell-to cell viral fusion assay was adapted from a cell-free
virion fusion assay [40]. HeLa donor cells were cotransfected with
Figure 5. Tetherin promotes transfer of large viral patches and inhibits productive infection. (a) Distribution of Gag and tetherin. Jurkat
target cells were stained, after 1 h of contact with DVpu-infected MT4C5, for Gag (green) and tetherin (red). A representative image from 5
independent experiments is shown. (b) Live video-microscope imaging of transferred virus on target cells. Actin-RFP Jurkat target cells, incubated for
4 hours with HIV-GagGFP WT or DVpu transfected Hela donor cells, were harvested and plated on fibronectin-coated micro-dish. Images were taken
every 5 minutes for 10 hours. Elapsed time after the beginning of acquisition is indicated. 2D maximum-projection of the images is shown. The scale
bar represents 10 mm. Corresponding sequences are available as supplementary Videos S3 (HIV-GagGFP WT) and S4 (HIV-GagGFP DVpu). (c)
Quantification of WT or DVpu Gag-GFP fluorescence on Jurkat target cells after 2 h incubation with Hela donor cells. The virus-associated
fluorescence was measured for each condition on at least 50 individual cells. The results are expressed as the mean fluorescence intensity of viral
aggregates per Gag-GFP positive cell 6 sd. Results are representative of 3 independent experiments. *p,0.05 (Mann-Whitney test). (d) Time course
analysis of HIV DNA synthesis in Jurkat cells by qPCR. A representative experiment is shown on the left. Target cells were treated or not with
nevirapine (NVP), a reverse transcriptase inhibitor, after the coculture. (e) Mean 6sd of 3 independent experiments is shown on the right (20 h time
point).
doi:10.1371/journal.ppat.1000955.g005
Figure 6. Tetherin reduces fusion after viral transfer to target cells. (a) Schematic representation of the viral fusion assay after cell-to-cell
transfer. (b) HIV fusion analyzed by cytometry. Jurkat T cells were cocultivated with donor Hela cells for 2 h, harvested and incubated at room
temperature for 2 h with CCF2-AM. Viral fusion was evaluated by measuring the percentage of cells positive for cleaved CCF2-AM. A representative
experiment is shown. (c) The percentage of cleaved-CCF2-AM+ cells in 7 independent experiments is shown along with the mean value (black line).
*p,0.05; **p,0.01 (Mann-Whitney test).
doi:10.1371/journal.ppat.1000955.g006
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beta-lactamase (Vpr-BlaM)(a kind gift from Warner Greene) [40].
For each plasmid 1 mg was used to transfect 106 cells. After 2 h of
coculture with HeLa donor cells (when stated, cocultures where
gently shaken to inhibit intercellular contacts), Jurkat targets were
harvested, washed and loaded with the CCF2-AM loading kit
(Invitrogen) in the presence of 1.8 mM Probenecid (Sigma). Cells
were incubated 2 h at room temperature then washed and fixed.
The cleaved CCF2-AM fluorescence (excitation at 405 nm,
emission at 450 nm) was measured by flow cytometry on a
FacsCanto II (BD).
Quantification of cell conjugates
Quantification was performed by visual observation of multiple
low-power fields, directly at the microscope or after image
acquisition. The total number of infected cells was counted. Cell
conjugates were defined as pairs or groups of cells closely apposed
among which at least one donor was Gag+. The % of infected cells
with a capping of Gag or THN at the junction sites with targets
was scored by visual examination.
Quantification of Gag+ target cells
Quantification of target cells displaying large Gag+ aggregates
was performed by visual observation of multiple low-power fields,
directly at the microscope or after image acquisition. The total
number of cells with Gag staining, and the % of cells displaying
large aggregates of Gag at the cell surface were scored by visual
examination. Alternatively, 3D images of the target cells were
summed in the Volocity software (Perkin Elmer). Individual
GagGFP+ cells were outlined manually with the ImageJ software.
Viral aggregates fluorescence for each cell was measured above a
6.1% threshold and substracted of GagGFP-negative cell associ-
ated background.
Live imaging
For live visualization of HIV movements in conjugates of
infected and target cells, Jurkat cells were electroporated with
pNL4-3 and pNLC4-3
EGFP proviral vectors or their Vpu deleted
counterparts, 18–24 hours prior imaging. Cells were also cotrans-
fected with a centrin-RFP expressing vector, to visualize the
centrosome of donor cells (a kind gift of David Vaux).
Electroporation of 20610
6 cells with 10 mg of proviral vectors,
and 5 mg of centrin-RFP were performed with Gene Pulser Xcell
(Bio-Rad). Jurkat cells, stably transduced with actin-RFP (actin-
RFP Jurkat) were used as targets. Donors and targets were mixed
in Hepes RPMI 10% FCS medium. Image acquisition began
immediately after mixing cells, using a confocal spinning disk
microscope in sealable microdishes (IBIDI, Germany) at 37uC. A
complete 3D image was acquired every 20 seconds for 2 hours.
For the observation of viruses after transfer to targets, Jurkat-
actinRFP were incubated for 4 hours at 37uC with HeLa donor
cells co-transfected with pNL4-3 and pNLC4-3
EGFP proviral
vectors or DVpu counterparts. Target cells were then harvested
and plated on fibronectin coated sealable micro-dishes for
imaging. Imaging was done at 37uC, 5% CO2 with a confocal
spinning disk microscope (ultraView VoX, Perkin-Elmer). A
complete 3D image was acquired every 5 min for 10 hours.
Supporting Information
Figure S1 (a) Tetherin surface levels in Hela cells stably
expressing a control shRNA (continuous line) or an shRNA
targeting tetherin (Hela-THN- cells)(dotted line). (b) Dose response
analysis of the effect of tetherin. 293T cells donor cells were
cotransfected with WT (left panel) or DVpu (right panel) HIV
proviruses (1 mg), along with the indicated doses of control (white
squares) or a tetherin expression plasmid (black squares). Cells
were then cocultivated with target Jurkat cells for 2 h. The
percentage of Gag+ cells in targets, at different time points after
harvesting the targets, is shown. Each panel is representative of 2
(20 ng and 200 ng) or 6 (100 ng) transfection experiments. The
effect of tetherin on viral release was assessed by measuring
the levels of Gagp24 in the supernatants of transfected cells
(right panels). Results are presented as the ratio of Gag p24
in supernatants, over total levels of Gag (supernatants + cell
associated p24).
Found at: doi:10.1371/journal.ppat.1000955.s001 (0.58 MB TIF)
Figure S2 Tetherin reduces HIV cell-to-cell transmission from
CEM lymphoid cells. (a) Tetherin surface levels in CEM cells
stably expressing a control shRNA (continuous line) or an shRNA
targeting tetherin (CEM-THN- cells)(dotted line) (b) HIV cell-to-
cell transfer. Donor CEM cells expressing (black squares) or not
(white squares) tetherin (THN) were infected with HIV-DVpu and
cocultivated with Jurkat target T cells. The appearance of Gag+
cells in targets was measured by flow-cytometry at the indicated
time points (in hours). A representative experiment is shown on the
left. The mean 6 sd of 3 independent experiments is shown on the
right (20 h time point).
Found at: doi:10.1371/journal.ppat.1000955.s002 (0.27 MB TIF)
Figure S3 Tetherin accumulates with Gag at the virological
synapse. (a) Distribution of Gag and tetherin (THN) in non-
infected (NI), WT or DVpu HIV-infected MT4C5 cells. MT4C5
cells were stained for HIV-1 Gag (green) and tetherin (red).
Representative images from 6 independent experiments are
shown. (b) Localization of Gag (green) and tetherin (red) at the
virological synapse between WT or DVpu HIV-infected MT4C5
cells, and far-red-dye labelled Jurkat targets (blue). The Jurkat cells
used in this experiment are tetherin-negative, to visualize tetherin
originating from donor cells. Representative images from 5
independent experiments are shown.
Found at: doi:10.1371/journal.ppat.1000955.s003 (2.66 MB TIF)
Figure S4 Aspect of viral patches transferred to Jurkat cells
analyzed by SEM. Correlative electron microscopy analysis of
Jurkat target cells after coculture with HIV-GagGFP DVpu-
transfected Hela donor cells. Cells are stained with anti-Env MAb
coupled to 20 nm-gold particles (appearing as white dots).
Found at: doi:10.1371/journal.ppat.1000955.s004 (1.17 MB TIF)
Figure S5 Characteristics of viral patches transferred to Jurkat
cells. WT or DVpu HIV-infected HeLa were cocultivated with far-
red dye-labelled Jurkat cells for 2 h. Targets were then harvested
and analyzed (a) Distribution of Gag (green) and Env (red) (b)
Distribution of Gag (green) and cholera toxin (ChTx) (red)
(c) Distribution of Gag (green) and tetherin (THN) (red).
Representative images from at least 3 independent experiments
are shown. In panel c, tetherin-negative Jurkat cells were used as
targets, to visualize tetherin originating from donor HeLa cells.
(ChTx-FITC was unusually pseudo-colored in red and Gagp24-
Cy3 in green for the sake of clarity).
Found at: doi:10.1371/journal.ppat.1000955.s005 (2.49 MB TIF)
Figure S6 Tetherin reduces R5 HIV cell-to-cell transmission. (a)
Hela donor cells expressing (black circles) or not expressing (white
circles) tetherin (THN) were infected with WT (upper panel) or
DVpu (lower panel) AD8, a R5-tropic HIV. Cells were then
cocultivated with target MT4C5 cells. The percentage of Gag+ cells
in targets, at different time points is shown in this experiment,
representative of 2 independent ones. (b) Distribution of transferred
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CCR5) cells (left panels), or primary T cells (which are CCR5+)
(right panels), labelled with far-red dye (blue) were harvested after
2 h of contact with WT or DVpu AD8 transfected HeLa.
Representative images of Gag signal on target cells are shown.
Found at: doi:10.1371/journal.ppat.1000955.s006 (1.21 MB TIF)
Figure S7 Tetherin reduces fusion after viral transfer to target
cells. HIV fusion analyzed by cytometry, as detailed in Figure 6.
Jurkat T cells were cocultivated with donor Hela cells (which are
tetherin +) for 2 h, harvested and incubated at room temperature
for 2 h with CCF2-AM. Viral fusion was evaluated by measuring
the percentage of cells positive for cleaved CCF2-AM. When
stated, cocultures were gently shaken to inhibit intercellular
contacts A representative experiment (from 7 without shaking
and 2 with shaking) is shown.
Found at: doi:10.1371/journal.ppat.1000955.s007 (0.45 MB TIF)
Video S1 Live video-microscopic imaging of cell-to-cell transfer.
Jurkat cells transfected with HIV-GagGFP WT were mixed with
actin-RFP expressing jurkat targets and imaged immediately.
Elapsed time after mixing is indicated. A three-dimensional image
was acquired every 20 seconds for 2 hours.
Found at: doi:10.1371/journal.ppat.1000955.s008 (4.37 MB
MOV)
Video S2 Live video-microscopic imaging of cell-to-cell transfer.
Jurkat cells transfected with DVpu were mixed with actin-RFP
expressing jurkat targets and imaged immediately. Elapsed time
after mixing is indicated. A three-dimensional image was acquired
every 20 seconds for 2 hours.
Found at: doi:10.1371/journal.ppat.1000955.s009 (1.82 MB
MOV)
Video S3 Live video-microscopic imaging of HIV WT on Jurkat
target cells after 4 hours incubation with transfected Hela donor
cells. A complete three-dimensional image was acquired every 5
minutes. Elapsed time after the beginning of acquisition is
indicated.
Found at: doi:10.1371/journal.ppat.1000955.s010 (2.13 MB
MOV)
Video S4 Live video-microscopic imaging of DVpu on Jurkat
target cells after 4 hours incubation with transfected Hela donor
cells. A complete three-dimensional image was acquired every 5
minutes. Elapsed time after the beginning of acquisition is
indicated.
Found at: doi:10.1371/journal.ppat.1000955.s011 (1.13 MB
MOV)
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